NeoGenomics to present new data at AMP 2024
Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment
Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment
Enhancing breast cancer diagnostics with precision, efficiency, and improved grading consistency for better patient outcomes
How cross-disciplinary collaboration and earlier recognition can transform outcomes for patients with Crohn’s disease and ulcerative colitis
This innovative technology aims to improve acute care outcomes, particularly for myocardial infarction diagnosis.
Roche’s Elecsys Amyloid Plasma Panel shows high accuracy in ruling out Alzheimer's, offering new hope for early and less invasive diagnostics
A study suggests a new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer
New suite of scanners and software designed to streamline slide analysis, enhance diagnostic accuracy, and accelerate cancer research.
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital PCR technology
This partnership is revolutionizing bladder cancer diagnostics with seamless access to non-invasive genomic testing and enhanced clinical efficiency
In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection.